Where I see patients (1)
Model based assessment of food and acid reducing agent effects on oral absorption of mezigdomide (CC-92480), a novel cereblon E3 ligase modulator.
CPT: pharmacometrics & systems pharmacology
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.
The New England journal of medicine
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.